
Advertise on podcast: The HemOnc Pulse
Rating
4.8from
This podcast has
89 episodes
Language
EnglishPublisher
Rahul Banerjee, MDExplicit
No
Date created
2022/12/14
Latest episode
2026/10/30
Average duration
15 min.
Release period
30 days
Description
Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.
Unlock The HemOnc Pulse podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from The HemOnc Pulse podcast
Putting AI to Work in Blood Cancer Clinical Trials
2026/10/30
The HemOnc Pulse host, Rahul Banerjee, MD, of Fred Hutchinson Cancer Center, returns for Part 2 of a conversation on the evolving role of AI in hematologic oncology. He is joined by Louis Williams, MD, of Cleveland Clinic, to discuss AI applications in blood cancer research, including clinical trial matching and design, data analysis, safety oversight, and streamlining clinical trial operations.
The Transformative Potential of AI in Hematologic Malignancies
2026/10/27
How is AI transforming hematologic cancer care? In this episode of The HemOnc Pulse, Rahul Banerjee, MD, of the Fred Hutchinson Cancer Institute, interviews Louis Williams of Cleveland Clinic on this topic. Together, the experts explore AI scribes, machine learning, genomic data, early detection, and how AI could reshape treatment decisions and patient monitoring.
Rewriting the Treatment Playbook for MDS/MPN and Myelofibrosis
2026/08/14
In this Editor’s Special episode of The HemOnc Pulse, MD Anderson Cancer Center’s Naval Daver, MD, and Naveen Pemmaraju, MD, discuss MDS/MPN overlap conditions and research examining combination therapy with ruxolitinib and azacitidine (AZA), including its potential to improve disease response, symptom control, and outcomes.
Taking Bispecific Antibodies Outpatient: Lessons From the Front Lines
2026/07/29
How can bispecific antibodies be safely delivered outside the hospital? Rahul Banerjee, MD and Ajay Nooka, MD discuss outpatient step-up dosing, prophylactic tocilizumab, CRS management, and practical tips for implementing bispecific therapy in academic and community practice.
Community-Based CAR-T Therapy: Expanding Access, Navigating Challenges
2026/06/08
In this episode of HemOnc Pulse, host Dr. Rahul Banerjee of Fred Hutchinson Cancer Center sits down with Dr. Gary Simmons, a hematologist-oncologist at Virginia Oncology Associates, to explore the evolving role of community-based cellular therapy programs and the future of patient access to innovative treatments.
Cutting GVHD Risk: What’s Changing in Allogeneic Transplants?
2026/03/30
Learn how new approaches in allogeneic transplants, from PTCy to innovative regimens, are helping reduce GVHD and improve patient outcomes with special guest Sagar S. Patel, MD of University of Utah Health.
MRD at the Regulatory Crossroads in Multiple Myeloma
2026/02/07
In this Editor’s Special Episode of The HemOncPulse, a conversation with Nicholas Richardson, DO, MPH, vice president of clinical development at Precision for Medicine, focuses on the evolving regulatory role of measurable residual disease in multiple myeloma clinical trials. The discussion is designed to contextualize recent FDA draft guidance for a broad clinical and research audience.
The Data Problem in T-Cell Lymphoma Care
2026/01/27
In this episode of TheHemOnc Pulse, Rahul Banerjee, MD, speaks with Francine Foss, MD, professor of medicine and dermatology at Yale School of Medicine, about the evolving landscape of T-cell lymphomas. Dr Foss discusses the unique challenges of studying and treating rare diseases such as cutaneous T-cell lymphoma and explains why real-world data are essential to closing evidence gaps. The conversation highlights the role of collaborative registries in tracking treatment patterns, outcomes, and access to care across community and academic settings. Dr Foss also shares how both clinicians and patients can participate in these efforts to strengthen research, inform future clinical trials, and improve outcomes for patients with T-cell lymphomas.
XPO1 Inhibition Across the Myeloma Journey
2025/12/26
This Editor’s Special Episode of The HemOnc Pulse features Paul G. Richardson, MD, of Dana-Farber Cancer Institute, discussing treatment strategies for relapsed/refractory multiple myeloma and where selinexor-based regimens fit in today’s evolving landscape. Drawing from real-world cases, Dr. Richardson explores care for patients before CAR T, after CAR T relapse, and in between—highlighting how selinexor can be used flexibly across multiple lines, including as a bridge to future immunotherapies. The conversation emphasizes individualized, dynamic treatment planning to balance disease control, tolerability, and long-term goals in an increasingly complex era of myeloma care.
Holding the Line in AML: Real-World Care Meets Breakthrough Trials
2025/12/20
Dr. Eunice Wang joins host Rahul Banerjee, MD, for a clinician-focused discussion on AML, treatment complexity, and real-world leukemia management in today’s evolving therapeutic landscape.
Under the Hood: Exploring the Genomic Engines of Smoldering Myeloma
2025/10/17
In this episode of The HemOnc Pulse, host Melissa speaks with Omar Nadeem, MD, Senior Physician at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, about emerging genomic insights in smoldering multiple myeloma. The discussion focuses on recent research showing how molecular profiling can improve understanding of disease progression and refine risk stratification beyond traditional clinical models.
Dr. Nadeem highlights how genomic data may help distinguish patients with smoldering myeloma who are at higher risk of progression from those likely to remain stable, offering the potential to guide more personalized treatment decisions. The conversation also explores the evolving landscape of precursor plasma cell disorders and the role of immunotherapy, including CAR T-cell therapy, in clinical management.
Toxicity, Time, and the Patient Experience in Blood Cancers
2025/10/03
Dr. Rahul Banerjee interviews Dr. Ajay Major on patient-reported outcomes, toxicity reporting, and patient engagement in blood cancer clinical trials.
Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
2025/10/01
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.
Clinical Advances in Myeloma: A Nordic Perspective
2025/09/12
Host Rahul Banerjee, MD, speaks with Drs. Frederik Schjesvold and Frida Askeland on myeloma trial results, relevance in the IMROZ/CEPHEUS era, and advances in treating elderly, frail patients.
Grand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints
2025/09/07
MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.
Podcast reviews
Read The HemOnc Pulse podcast reviews
wesSta2023Wes 2023/07/13
Great one
The best hematology only podcast out there. Highly recommended.
Podcast sponsorship advertising
Start advertising on The HemOnc Pulse relevant audience podcasts
You may also like to advertise on these Podcasts

4.713049379
The Tim Dillon Show
The Tim Dillon Show

4.116091470
The Tucker Carlson Show
Tucker Carlson Network

4.828110458
Huberman Lab
Scicomm Media

4.240683
To Be The Man
Podcast Heat | Cumulus Podcast Network

4.41511782000
The Ben Shapiro Show
The Daily Wire

4.2155648
TENNIS.com Podcast
TENNIS.com Podcast/Tennis Channel Podcast Network

4.510879779
The Joe Budden Podcast
The Joe Budden Network

4.611699506
The Bulwark Podcast
The Bulwark

4.711530393
Matt and Shane's Secret Podcast
Matt McCusker & Shane Gillis

4.72577183
Smosh Reads Reddit Stories
Smosh